+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Chemotherapy At Home Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product (Chemotherapy Drugs v/s Chemotherapy Infusion Pumps), By Route of Administration, By Cancer Type, By Company, and By Region

  • PDF Icon

    Report

  • 112 Pages
  • December 2022
  • Region: Global
  • TechSci Research
  • ID: 5697741
Free Webex Call
10% Free customization

The Major Factors Include Growing Incidences of Different Types of Cancer, and Rising Preferences Towards At-Home Medical Care, are Bolstering the Growth of the Market

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The global chemotherapy at home services market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of different types of cancer, and rising preferences towards at-home medical care, are bolstering the growth of the market. Chemotherapy is a medical practice that is mainly conducted for cancer patients. It uses powerful chemicals to kill fast growing cells in human body. The other factors supporting the market’s growth are growing need to reduce the period of inpatient stays, the increasing population, changing societal behavior, increasing government investments, growth in geriatric population, and technological advancements in field of chemotherapy devices. Also, strategic partnerships and collaborations are fueling the growth of the market. For instance, CVS Health and the Cancer Treatments Centers of America (CTCA) worked in partnership to bolster the access to chemotherapy at home for eligible patients.

Increasing Incidence of Cancer and Rise in Geriatric Population

Rise in occurrences of various types of cancer such as lung cancer, cervical cancer, breast cancer, and others, are propelling the growth of the market. Cancer is considered as second largest cause of mortality and disability across the globe. According to National Cancer Institute, roughly 5.5 million people in the United States are affected by cancer. This number is projected to rise to 20.3 million by 2026. Owing to the rapid increase in number of patients suffering from cancer, the surge in demand for chemotherapy rises, which augments the growth of chemotherapy at home services market, globally. Furthermore, rising geriatric population is also a key factor contributing the growth of the market. For instance, according to the U.S. Census Bureau, approximately 77.0 million people will be aged 65 & above by 2034, and this number is anticipated to reach 94.7 million by 2060.

Increasing Preference for At-Home Medical Care and Various Technological Advancements

Rising consumer inclination toward at-home medical care is bolstering the market growth, globally. The limited movement capabilities by elderly population are fueling the growth of the market. Rising incidences of hospital infections, and cost effectiveness of these devices are curbing the market growth. For instance, in 2021, as per the study, titled ‘Predicting Patients at Risk for Prolonged Hospital Stays’, only 1.2% of hospital stays lasted more than 21 days. Moreover, various initiatives are taken by government and non-government organization to bolster the growth of the market. In 2021, VS Health and the Cancer Treatments Centers of America (CTCA) collaborated to augment the access to chemotherapy at home for qualified patients.

Market Segmentation

The global chemotherapy at home services market is segmented into product, route of administration, cancer type, and company. Based on product, the market is divided into chemotherapy drugs and chemotherapy infusion pumps. Based on route of administration, the market is segmented into oral and intravenous. Based on cancer type, the market is segmented into breast cancer, blood cancer, ovarian cancer, colorectal cancer, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising prevalence of different type of cancer and rising geriatric population base in the country.

Market Players

Portea Medical Pvt. Ltd., HealthCare atHOME, Ubiqare Health Pvt. Ltd., Vitalis Health and Home Care Pty Ltd, Medibank Private Limited, Advocate Medical Group, View Health Pty Ltd, and CVS Health Corporation are some of the leading companies operating in the market.

Report Scope:

In this report, global chemotherapy at home services market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Chemotherapy At Home Services Market, By Product:

  • Chemotherapy Drugs
  • Chemotherapy Infusion Pumps

Chemotherapy At Home Services Market, By Route of Administration:

  • Oral
  • Intravenous

Chemotherapy At Home Services Market, By Cancer Type:

  • Breast Cancer
  • Blood Cancer
  • Ovarian Cancer
  • Colorectal Cancer
  • Others

Chemotherapy At Home Services Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Europe & CIS
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Chemotherapy At Home Services Market

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.



This product will be delivered within 1-3 business days.

Table of Contents

1. Service Overview2. Research Methodology3. Impact of COVID-19 on Global Chemotherapy At Home Services Market4. Executive Summary
5. Voice of Customer
5.1. Cancer Prevalence, By Gender
5.2. Cancer Prevalence, By Age Group
5.3. Cancer Prevalence, By Region
5.4. Factors Contributing Switch To Chemotherapy At Home
5.5. Barriers To Adoption of Chemotherapy At Home Services
6. Global Chemotherapy At Home Services Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Chemotherapy Drugs v/s Chemotherapy Infusion Pumps)
6.2.2. By Route of Administration (Oral v/s Intravenous)
6.2.3. By Cancer Type (Breast Cancer, Blood Cancer, Ovarian Cancer, Colorectal Cancer, Others)
6.2.4. By Company (2021)
6.2.5. By Region
6.3. Market Map
7. North America Chemotherapy At Home Services Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Route of Administration
7.2.3. By Cancer Type
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Chemotherapy At Home Services Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Route of Administration
7.3.1.2.3. By Cancer Type
7.3.2. Mexico Chemotherapy At Home Services Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Route of Administration
7.3.2.2.3. By Cancer Type
7.3.3. Canada Chemotherapy At Home Services Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Route of Administration
7.3.3.2.3. By Cancer Type
8. Europe Chemotherapy At Home Services Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Route of Administration
8.2.3. By Cancer Type
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France Chemotherapy At Home Services Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Route of Administration
8.3.1.2.3. By Cancer Type
8.3.2. Germany Chemotherapy At Home Services Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Route of Administration
8.3.2.2.3. By Cancer Type
8.3.3. United Kingdom Chemotherapy At Home Services Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Route of Administration
8.3.3.2.3. By Cancer Type
8.3.4. Italy Chemotherapy At Home Services Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Route of Administration
8.3.4.2.3. By Cancer Type
8.3.5. Spain Chemotherapy At Home Services Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Route of Administration
8.3.5.2.3. By Cancer Type
9. Asia-Pacific Chemotherapy At Home Services Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Route of Administration
9.2.3. By Cancer Type
9.2.4. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Chemotherapy At Home Services Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Route of Administration
9.3.1.2.3. By Cancer Type
9.3.2. India Chemotherapy At Home Services Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Route of Administration
9.3.2.2.3. By Cancer Type
9.3.3. Japan Chemotherapy At Home Services Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Route of Administration
9.3.3.2.3. By Cancer Type
9.3.4. South Korea Chemotherapy At Home Services Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Route of Administration
9.3.4.2.3. By Cancer Type
9.3.5. Australia Chemotherapy At Home Services Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product
9.3.5.2.2. By Route of Administration
9.3.5.2.3. By Cancer Type
10. South America Chemotherapy At Home Services Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Route of Administration
10.2.3. By Cancer Type
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Chemotherapy At Home Services Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Route of Administration
10.3.1.2.3. By Cancer Type
10.3.2. Argentina Chemotherapy At Home Services Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Route of Administration
10.3.2.2.3. By Cancer Type
10.3.3. Colombia Chemotherapy At Home Services Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Route of Administration
10.3.3.2.3. By Cancer Type
11. Middle East and Africa Chemotherapy At Home Services Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Route of Administration
11.2.3. By Cancer Type
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Chemotherapy At Home Services Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Route of Administration
11.3.1.2.3. By Cancer Type
11.3.2. Saudi Arabia Chemotherapy At Home Services Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Route of Administration
11.3.2.2.3. By Cancer Type
11.3.3. UAE Chemotherapy At Home Services Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Route of Administration
11.3.3.2.3. By Cancer Type
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Portea Medical Pvt. Ltd.
14.2. HealthCare atHOME
14.3. Ubiqare Health Pvt. Ltd.
14.4. Vitalis Health and Home Care Pty Ltd
14.5. Medibank Private Limited.
14.6. Advocate Medical Group
14.7. View Health Pty Ltd
14.8. CVS Health Corporation
15. Strategic Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Portea Medical Pvt. Ltd.
  • HealthCare atHOME
  • Ubiqare Health Pvt. Ltd.
  • Vitalis Health and Home Care Pty Ltd
  • Medibank Private Limited.
  • Advocate Medical Group
  • View Health Pty Ltd
  • CVS Health Corporation